CH-4051

· Chelsea Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CH-4051, covering 2013-04-15 to 2013-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) [Phase 2]